Gentian Lluri

Gentian Lluri practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Gentian Lluri's NPI, 1154595346, was assigned on April 17, 2008. Gentian Lluri graduated from The Robert Larner, M.D. College of Medicine in 2008. Gentian Lluri holds California license 114499.

Gentian Lluri's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Gentian Lluri's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Gentian Lluri is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCLA Medical Group. Dmand AI also links Gentian Lluri to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gentian Lluri practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Gentian Lluri's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Gentian Lluri is board certified in adult congenital heart disease by the American Board of Internal Medicine. Dmand AI has Gentian Lluri's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, congestive heart failure and coronary artery disease among the conditions Gentian Lluri treats.

CMS data shows 3,223 Medicare services from Gentian Lluri across 23 procedure codes in 2024, for 1,636 Medicare patients. Medicare paid $161,875 for them.

CMS counts 1,636 Medicare patients who saw Gentian Lluri in 2024. The largest group is 65 to 74, with 620 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gentian Lluri's median patient age at 55, with 47% women.

In 2024, Gentian Lluri wrote 1,668 Medicare Part D claims for 253 patients. 83% of them were for generic drugs. CMS names the drug for 1,440 of them, across 32 drugs with 11 or more claims each, at $261,657 in total drug cost. In 2023, CMS named 1,287 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Gentian Lluri for performance year 2024, reported as part of a group. Gentian Lluri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gentian Lluri as offering telehealth.

Dmand AI links 17 papers to Gentian Lluri, published from 2014 to 2025. 2017 was the busiest year, with 4. Gentian Lluri's most frequent co-authors are Jamil Anis Aboulhosn, MD, Reshma M. Biniwale, MD and Leigh Christopher Reardon, MD.

Dmand AI links Gentian Lluri to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency and Heart Valve Diseases.

CMS Open Payments shows 35 general payments to Gentian Lluri from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Edwards Lifesciences Corporation paid the most, $493.

Gentian Lluri graduated from The Robert Larner, M.D. College of Medicine in 2008. Gentian Lluri is a member of ACC.

Gentian Lluri is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.